| James Van Riper, DO | |
|
1680 Antilley Rd Ste 321, Abilene, TX 79606-5279 | |
| (325) 695-4969 | |
| (325) 695-4534 |
| Full Name | James Van Riper |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 27 Years |
| Location | 1680 Antilley Rd Ste 321, Abilene, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1467446484 | NPI | - | NPPES |
| 144813601 | Medicaid | TX |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | K5421 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| United Regional Health Care System | Wichita falls, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Texoma Womens Clinic Pa | 7315942109 | 4 |
News Archive
Myriad Genetics, Inc., a leader in molecular diagnostics and personalized medicine, announced today that it has launched riskScore, a new clinically validated precision medicine tool to enhance its myRisk Hereditary Cancer test. riskScore quantifies a woman's risk of developing breast cancer by combining genetic markers throughout the genome with her family and clinical history.
Boston-based Senior Living Residences (SLR), a company with a 15-year history of successful ownership, lease-up and management of senior housing communities, has further burnished its track record of robust lease-up of new assisted living facilities even as other companies in the senior housing industry are reporting the negative impact of the current economic downturn.
Boehringer Ingelheim Pharmaceuticals, Inc. and the Duke Clinical Research Institute (DCRI) announced today the expansion of the Idiopathic Pulmonary Fibrosis – PROspective Outcomes (IPF-PRO) Registry, a patient registry developed to uncover insights into IPF, a rare and serious lung disease. The expansion will increase the study enrollment from 300 patients at 18 study sites to 1,500 patients at approximately 45 sites, creating the largest registry of newly diagnosed IPF patients.
Phase 2 trial results published in the March issue of Hepatology, a journal of the American Association for the Study of Liver Diseases, suggests the potential for Glycerol Phenylbutyrate (GPB) to reduce hepatic encephalopathy episodes in patients with cirrhosis, with a safety profile similar to placebo.
› Verified 5 days ago
| Entity Name | Texas Tech University Health Sciences Center Odessa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1407845084 PECOS PAC ID: 8426044256 Enrollment ID: O20040607001561 |
News Archive
Myriad Genetics, Inc., a leader in molecular diagnostics and personalized medicine, announced today that it has launched riskScore, a new clinically validated precision medicine tool to enhance its myRisk Hereditary Cancer test. riskScore quantifies a woman's risk of developing breast cancer by combining genetic markers throughout the genome with her family and clinical history.
Boston-based Senior Living Residences (SLR), a company with a 15-year history of successful ownership, lease-up and management of senior housing communities, has further burnished its track record of robust lease-up of new assisted living facilities even as other companies in the senior housing industry are reporting the negative impact of the current economic downturn.
Boehringer Ingelheim Pharmaceuticals, Inc. and the Duke Clinical Research Institute (DCRI) announced today the expansion of the Idiopathic Pulmonary Fibrosis – PROspective Outcomes (IPF-PRO) Registry, a patient registry developed to uncover insights into IPF, a rare and serious lung disease. The expansion will increase the study enrollment from 300 patients at 18 study sites to 1,500 patients at approximately 45 sites, creating the largest registry of newly diagnosed IPF patients.
Phase 2 trial results published in the March issue of Hepatology, a journal of the American Association for the Study of Liver Diseases, suggests the potential for Glycerol Phenylbutyrate (GPB) to reduce hepatic encephalopathy episodes in patients with cirrhosis, with a safety profile similar to placebo.
› Verified 5 days ago
| Entity Name | Michael V Shelton Md Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356374854 PECOS PAC ID: 7214963958 Enrollment ID: O20050713000840 |
News Archive
Myriad Genetics, Inc., a leader in molecular diagnostics and personalized medicine, announced today that it has launched riskScore, a new clinically validated precision medicine tool to enhance its myRisk Hereditary Cancer test. riskScore quantifies a woman's risk of developing breast cancer by combining genetic markers throughout the genome with her family and clinical history.
Boston-based Senior Living Residences (SLR), a company with a 15-year history of successful ownership, lease-up and management of senior housing communities, has further burnished its track record of robust lease-up of new assisted living facilities even as other companies in the senior housing industry are reporting the negative impact of the current economic downturn.
Boehringer Ingelheim Pharmaceuticals, Inc. and the Duke Clinical Research Institute (DCRI) announced today the expansion of the Idiopathic Pulmonary Fibrosis – PROspective Outcomes (IPF-PRO) Registry, a patient registry developed to uncover insights into IPF, a rare and serious lung disease. The expansion will increase the study enrollment from 300 patients at 18 study sites to 1,500 patients at approximately 45 sites, creating the largest registry of newly diagnosed IPF patients.
Phase 2 trial results published in the March issue of Hepatology, a journal of the American Association for the Study of Liver Diseases, suggests the potential for Glycerol Phenylbutyrate (GPB) to reduce hepatic encephalopathy episodes in patients with cirrhosis, with a safety profile similar to placebo.
› Verified 5 days ago
| Entity Name | Texoma Womens Clinic Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1104854777 PECOS PAC ID: 7315942109 Enrollment ID: O20060929000273 |
News Archive
Myriad Genetics, Inc., a leader in molecular diagnostics and personalized medicine, announced today that it has launched riskScore, a new clinically validated precision medicine tool to enhance its myRisk Hereditary Cancer test. riskScore quantifies a woman's risk of developing breast cancer by combining genetic markers throughout the genome with her family and clinical history.
Boston-based Senior Living Residences (SLR), a company with a 15-year history of successful ownership, lease-up and management of senior housing communities, has further burnished its track record of robust lease-up of new assisted living facilities even as other companies in the senior housing industry are reporting the negative impact of the current economic downturn.
Boehringer Ingelheim Pharmaceuticals, Inc. and the Duke Clinical Research Institute (DCRI) announced today the expansion of the Idiopathic Pulmonary Fibrosis – PROspective Outcomes (IPF-PRO) Registry, a patient registry developed to uncover insights into IPF, a rare and serious lung disease. The expansion will increase the study enrollment from 300 patients at 18 study sites to 1,500 patients at approximately 45 sites, creating the largest registry of newly diagnosed IPF patients.
Phase 2 trial results published in the March issue of Hepatology, a journal of the American Association for the Study of Liver Diseases, suggests the potential for Glycerol Phenylbutyrate (GPB) to reduce hepatic encephalopathy episodes in patients with cirrhosis, with a safety profile similar to placebo.
› Verified 5 days ago
| Entity Name | Obhg Texas Holdings Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083917769 PECOS PAC ID: 3577713072 Enrollment ID: O20121018000279 |
News Archive
Myriad Genetics, Inc., a leader in molecular diagnostics and personalized medicine, announced today that it has launched riskScore, a new clinically validated precision medicine tool to enhance its myRisk Hereditary Cancer test. riskScore quantifies a woman's risk of developing breast cancer by combining genetic markers throughout the genome with her family and clinical history.
Boston-based Senior Living Residences (SLR), a company with a 15-year history of successful ownership, lease-up and management of senior housing communities, has further burnished its track record of robust lease-up of new assisted living facilities even as other companies in the senior housing industry are reporting the negative impact of the current economic downturn.
Boehringer Ingelheim Pharmaceuticals, Inc. and the Duke Clinical Research Institute (DCRI) announced today the expansion of the Idiopathic Pulmonary Fibrosis – PROspective Outcomes (IPF-PRO) Registry, a patient registry developed to uncover insights into IPF, a rare and serious lung disease. The expansion will increase the study enrollment from 300 patients at 18 study sites to 1,500 patients at approximately 45 sites, creating the largest registry of newly diagnosed IPF patients.
Phase 2 trial results published in the March issue of Hepatology, a journal of the American Association for the Study of Liver Diseases, suggests the potential for Glycerol Phenylbutyrate (GPB) to reduce hepatic encephalopathy episodes in patients with cirrhosis, with a safety profile similar to placebo.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| James Van Riper, DO Po Box 5409, Abilene, TX 79608-5409 Ph: (325) 695-4969 | James Van Riper, DO 1680 Antilley Rd Ste 321, Abilene, TX 79606-5279 Ph: (325) 695-4969 |
News Archive
Myriad Genetics, Inc., a leader in molecular diagnostics and personalized medicine, announced today that it has launched riskScore, a new clinically validated precision medicine tool to enhance its myRisk Hereditary Cancer test. riskScore quantifies a woman's risk of developing breast cancer by combining genetic markers throughout the genome with her family and clinical history.
Boston-based Senior Living Residences (SLR), a company with a 15-year history of successful ownership, lease-up and management of senior housing communities, has further burnished its track record of robust lease-up of new assisted living facilities even as other companies in the senior housing industry are reporting the negative impact of the current economic downturn.
Boehringer Ingelheim Pharmaceuticals, Inc. and the Duke Clinical Research Institute (DCRI) announced today the expansion of the Idiopathic Pulmonary Fibrosis – PROspective Outcomes (IPF-PRO) Registry, a patient registry developed to uncover insights into IPF, a rare and serious lung disease. The expansion will increase the study enrollment from 300 patients at 18 study sites to 1,500 patients at approximately 45 sites, creating the largest registry of newly diagnosed IPF patients.
Phase 2 trial results published in the March issue of Hepatology, a journal of the American Association for the Study of Liver Diseases, suggests the potential for Glycerol Phenylbutyrate (GPB) to reduce hepatic encephalopathy episodes in patients with cirrhosis, with a safety profile similar to placebo.
› Verified 5 days ago
Nicole C Bullock, DO Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 6250 Regional Plz, Suite 1010, Abilene, TX 79606 Phone: 325-428-5500 Fax: 325-428-5519 | |
Dr. Stuart Martin, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1924 Pine St, Suite 402, Abilene, TX 79601 Phone: 325-670-6860 Fax: 325-670-6861 | |
Dr. Jessica Ann Ortolano, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1850 Hickory St, Suite 200d, Abilene, TX 79601 Phone: 325-670-5385 Fax: 325-670-5389 | |
Jerry Sinclair, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1680 Antilley Rd, #380, Abilene, TX 79606 Phone: 325-691-1122 | |
Dr. Timothy Joseph Hill Ii, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1924 Pine St Ste 401b, Abilene, TX 79601 Phone: 325-670-4242 Fax: 833-437-1269 | |
Stefanie Bertie Mccain, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 19 Hospital Dr, Abilene, TX 79606 Phone: 325-690-0620 Fax: 325-690-0622 | |
Dr. Katherine Hall Jelliffe, MD Obstetrics & Gynecology Medicare: May Accept Medicare Assignments Practice Location: 1933 Pine St Ste A, Abilene, TX 79601 Phone: 325-692-0626 Fax: 325-692-0638 |